1887

Abstract

Abstract

We aim to improve Cisplatin Cancer Efficacy. Cisplatin was applied to MCF7 cells pre-incubated with menstrual hormones. Intracellular calcium was measured with fluorescence microscopy and was associated with reduced cell survival in contrast to Cisplatin application only. Syncing Cisplatin administration and menstrual cycle can enhance treatment.

Loading

Article metrics loading...

/content/papers/10.5339/qproc.2012.mutagens.3.73
2012-03-01
2019-08-17
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/papers/10.5339/qproc.2012.mutagens.3.73
Loading
  • Received: 15 May 2012
  • Accepted: 15 May 2012
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error